Optibrium

Optibrium is a private, revenue-generating software platform company founded in 2009 and headquartered in Cambridge, UK. It has developed a unified, AI-powered drug discovery platform centered on its StarDrop software, which is enhanced by specialized modules like Cerella for AI-guided discovery and BioPharmics for 3D molecular modelling. The company's business model is based on licensing its software to pharmaceutical and biotechnology R&D teams, offering both cloud-based and on-premise installations. Optibrium differentiates itself through a focus on user-friendly design for medicinal chemists, real-time collaboration tools, and a scientifically validated approach to compound prioritization.

StarDrop: A unified, modular software platform for AI-guided drug discovery, featuring data analysis, compound generation, molecular design, optimization, and real-time collaboration tools. Enhanced by Cerella (AI/ML) and BioPharmics (3D modelling) modules.

Operates in the competitive AI-driven drug discovery software market, competing with large public companies like Schrödinger, as well as other AI/ML platform providers such as Exscientia, Recursion, and BenevolentAI. Differentiation is based on a strong focus on user experience for medicinal chemists, an integrated modular platform, and scientifically validated methods.